Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 15 June

Paulina Peters
June 15, 2021

Your most asked EOFY questions answered

Bell Direct
June 14, 2021

Weekly Wrap 11 June

Jessica Amir
June 11, 2021

Morning Bell 11 June

Jessica Amir
June 11, 2021

Morning Bell 10 June

Sophia Mavridis
June 10, 2021

Morning Bell 9 June

Jessica Amir
June 9, 2021

Morning Bell 8 June

Jessica Amir
June 8, 2021

Morning Bell 7 June

Paulina Peters
June 7, 2021

Weekly Wrap 4 June

Jessica Amir
June 4, 2021

Morning Bell 4 June

Sophia Mavridis
June 4, 2021

Morning Bell 3 June

Jessica Amir
June 3, 2021